{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:40:18Z","timestamp":1793144418045,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Phenylketonuria (PKU) is an autosomal recessive inborn error of\n                    <jats:sc>l<\/jats:sc>\n                    -phenylalanine (Phe) metabolism. It is caused by a partial or complete deficiency of the enzyme phenylalanine hydroxylase (PAH), which is necessary for conversion of Phe to tyrosine (Tyr). This metabolic error results in buildup of Phe and reduction of Tyr concentration in blood and in the brain, leading to neurological disease and intellectual deficits. Patients exhibit retarded body growth, hypopigmentation, hypocholesterolemia and low levels of neurotransmitters. Here we report first attempt at creating a homozygous\n                    <jats:italic>Pah<\/jats:italic>\n                    knock-out (KO) (Hom) mouse model, which was developed in the C57BL\/6\u00a0J strain using CRISPR\/Cas9 where codon 7 (GAG) in\n                    <jats:italic>Pah<\/jats:italic>\n                    gene was changed to a stop codon TAG. We investigated 2 to 6-month-old, male, Hom mice using comprehensive behavioral and biochemical assays, MRI and histopathology. Age and sex-matched heterozygous\n                    <jats:italic>Pah<\/jats:italic>\n                    -KO (Het) mice were used as control mice, as they exhibit enough PAH enzyme activity to provide Phe and Tyr levels comparable to the wild-type mice. Overall, our findings demonstrate that 6-month-old, male Hom mice completely lack PAH enzyme, exhibit significantly higher blood and brain Phe levels, lower levels of brain Tyr and neurotransmitters along with lower myelin content and have significant behavioral deficit. These mice exhibit phenotypes that closely resemble PKU patients such as retarded body growth, cutaneous hypopigmentation, and hypocholesterolemia when compared to the age- and sex-matched Het mice. Altogether, biochemical, behavioral, and pathologic features of this novel mouse model suggest that it can be used as a reliable translational tool for PKU preclinical research and drug development.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-86663-8","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T06:03:51Z","timestamp":1617170631000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["CRISPR\/Cas9 generated knockout mice lacking phenylalanine hydroxylase protein as a novel preclinical model for human phenylketonuria"],"prefix":"10.1038","volume":"11","author":[{"given":"Kuldeep","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen S.","family":"Cornell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Kabiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Phipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitul","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fogle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyou","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulbenk","family":"Anarat-Cappillino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Geller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Errin","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Malley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"DeRiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Berthelette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao V.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth L.","family":"Thurberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh S.","family":"Bangari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirkka","family":"Kyostio-Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"key":"86663_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/306151a0","volume":"306","author":"SL Woo","year":"1983","unstructured":"Woo, S. L., Lidsky, A. S., G\u00fcttler, F., Chandra, T. & Robson, K. J. Cloned human phenylalanine hydroxylase gene allows prenatal diagnosis and carrier detection of classical phenylketonuria. Nature 306, 151\u2013155 (1983).","journal-title":"Nature"},{"key":"86663_CR2","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1021\/bi00324a002","volume":"24","author":"SC Kwok","year":"1985","unstructured":"Kwok, S. C., Ledley, F. D., DiLella, A. G., Robson, K. J. & Woo, S. L. Nucleotide sequence of a full-length complementary DNA clone and amino acid sequence of human phenylalanine hydroxylase. Biochemistry 24, 556\u2013561 (1985).","journal-title":"Biochemistry"},{"key":"86663_CR3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/humu.22980","volume":"37","author":"N Blau","year":"2016","unstructured":"Blau, N. Genetics of phenylketonuria: Then and now. Hum. Mutat. 37, 508\u2013515 (2016).","journal-title":"Hum. Mutat."},{"issue":"Suppl 1","key":"86663_CR4","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ymgme.2009.10.005","volume":"99","author":"PJ Anderson","year":"2010","unstructured":"Anderson, P. J. & Leuzzi, V. White matter pathology in phenylketonuria. Mol. Genet. Metab. 99(Suppl 1), S3-9 (2010).","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl 1","key":"86663_CR5","doi-asserted-by":"publisher","first-page":"S86","DOI":"10.1016\/j.ymgme.2009.10.016","volume":"99","author":"MJ de Groot","year":"2010","unstructured":"de Groot, M. J., Hoeksma, M., Blau, N., Reijngoud, D. J. & van Spronsen, F. J. Pathogenesis of cognitive dysfunction in phenylketonuria: Review of hypotheses. Mol. Genet. Metab. 99(Suppl 1), S86\u2013S89 (2010).","journal-title":"Mol. Genet. Metab."},{"key":"86663_CR6","first-page":"390","volume":"6","author":"PF Schuck","year":"2016","unstructured":"Schuck, P. F. et al. Phenylketonuria pathophysiology: On the role of metabolic alternations. Aging Dis. 6, 390\u2013399 (2016).","journal-title":"Aging Dis."},{"key":"86663_CR7","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.spen.2016.11.007","volume":"23","author":"MJ Gonzales","year":"2016","unstructured":"Gonzales, M. J., Gassio, R., Artuch, R. & Campistol, J. Impaired neurotransmission in early treated phenylketonuria patients. Semin. Pediatr. Neurol. 23, 332\u2013340 (2016).","journal-title":"Semin. Pediatr. Neurol."},{"key":"86663_CR8","first-page":"106","volume":"4","author":"L Mei","year":"2013","unstructured":"Mei, L., Song, P., Kokudo, N., Xu, L. & Tang, W. Current situation and prospects of newborn screening and treatment for Phenylketonuria in China\u2014Compared with the current situation in the United States, UK and Japan. Intractable Rare Dis. Res. 4, 106\u2013114 (2013).","journal-title":"Intractable Rare Dis. Res."},{"key":"86663_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13023-015-0283-0","volume":"10","author":"MZ Tansek","year":"2015","unstructured":"Tansek, M. Z. et al. Phenylketonuria screening and management in southeastern Europe\u2014Survey results from 11 countries. Orphanet J. Rare Dis. 10, 68\u201375 (2015).","journal-title":"Orphanet J. Rare Dis."},{"key":"86663_CR10","first-page":"31","volume":"29","author":"RA Williams","year":"2008","unstructured":"Williams, R. A., Mamotte, C. D. & Burnett, J. R. Phenylketonuria: an inborn error of phenylalanine metabolism. Clin. Biochem. Rev. 29, 31\u201341 (2008).","journal-title":"Clin. Biochem. Rev."},{"key":"86663_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ymgme.2010.05.017","volume":"101","author":"GM Enns","year":"2010","unstructured":"Enns, G. M. et al. Suboptimal outcomes in patients with PKU treated early with diet alone: Revisiting the evidence. Mol. Genet. Metab. 101, 99\u2013109 (2010).","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl 2","key":"86663_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF01799701","volume":"9","author":"F G\u00fcttler","year":"1986","unstructured":"G\u00fcttler, F. & Lou, H. Dietary problems of phenylketonuria: Effect on CNS transmitters and their possible role in behavior and neuropsychological function. J. Inherit. Metab. Dis. 9(Suppl 2), 169\u2013177 (1986).","journal-title":"J. Inherit. Metab. Dis."},{"key":"86663_CR13","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/geno.1996.4508","volume":"39","author":"JD McDonald","year":"1997","unstructured":"McDonald, J. D. & Charlton, C. K. Characterization of mutations at the mouse phenylalanine hydroxylase locus. Genomics 39, 402\u2013405 (1997).","journal-title":"Genomics"},{"key":"86663_CR14","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1093\/genetics\/134.4.1205","volume":"134","author":"A Shedlovsky","year":"1993","unstructured":"Shedlovsky, A., McDonald, J. D., Symula, D. & Dove, W. F. Mouse models of human phenylketonuria. Genetics 134, 1205\u20131210 (1993).","journal-title":"Genetics"},{"issue":"1","key":"86663_CR15","first-page":"S334","volume":"9","author":"CE Charron","year":"2004","unstructured":"Charron, C. E., Lewin, A. S. & Laipis, P. J. Evidence for dominant-negative interference in the Pahenu2 mouse model of PKU. Molec. Ther. 9(1), S334 (2004).","journal-title":"Molec. Ther."},{"key":"86663_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1006\/nimg.1994.1007","volume":"1","author":"S Kornguth","year":"1994","unstructured":"Kornguth, S., Anderson, M., Markley, J. L. & Shedlovsky, A. Near-microscopic magnetic resonance imaging of the brains of phenylalanine hydroxylase-deficient mice, normal littermates, and of normal BALB\/c mice at 9.4 tesla. Neuroimage 1, 220\u2013229 (1994).","journal-title":"Neuroimage"},{"key":"86663_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0006-8993(03)02354-0","volume":"971","author":"D Wahlsten","year":"2003","unstructured":"Wahlsten, D., Metten, P. & Crabbe, J. C. Survey of 21 inbred mouse strains in two laboratories reveals that BTBR T\/+ tf\/tf has severely reduced hippocampal commissure and absent corpus callosum. Brain Res. 971, 47\u201354 (2003).","journal-title":"Brain Res."},{"key":"86663_CR18","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1111\/j.1601-183X.2012.00802.x","volume":"7","author":"MO Bohlen","year":"2012","unstructured":"Bohlen, M. O., Jeremy, D., Bailoo, D., Jordan, R. L. & Wahlsten, D. Hippocampal commissure defects in crosses of four inbred mouse strains with absent corpus callosum. Genes Brain Behav. 7, 757\u2013766 (2012).","journal-title":"Genes Brain Behav."},{"key":"86663_CR19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1042\/bj2670399","volume":"267","author":"FD Ledley","year":"1990","unstructured":"Ledley, F. D., Grenett, H. E., Dunbar, B. S. & Woo, S. L. Mouse phenylalanine hydroxylase. Homology and divergence from human phenylalanine hydroxylase. Biochem. J. 267, 399\u2013405 (1990).","journal-title":"Biochem. J."},{"key":"86663_CR20","doi-asserted-by":"publisher","first-page":"e69782","DOI":"10.1371\/journal.pone.0069782","volume":"8","author":"Cudalbu","year":"2013","unstructured":"Cudalbu, et al. The C57BL\/6 mouse exhibits sporadic congenital portosystemic shunts. PLoS ONE 8, e69782 (2013).","journal-title":"PLoS ONE"},{"key":"86663_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/0300985811430696","volume":"49","author":"CF Brayton","year":"2012","unstructured":"Brayton, C. F., Treuting, P. M. & Ward, J. M. Pathobiology of aging mice and GEM: Background strains and experimental design. Vet. Pathol. 49, 85\u2013105 (2012).","journal-title":"Vet. Pathol."},{"key":"86663_CR22","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/nprot.2006.170","volume":"1","author":"RMJ Deacon","year":"2006","unstructured":"Deacon, R. M. J. Assessing nest building in mice. Nat. Protoc. 1, 1117\u20131119 (2006).","journal-title":"Nat. Protoc."},{"key":"86663_CR23","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1007\/PL00014371","volume":"159","author":"PR Huttenlocher","year":"2000","unstructured":"Huttenlocher, P. R. The neuropathology of phenylketonuria: Human and animal studies. Eur. J. Pediatr. 159, S102\u2013S106 (2000).","journal-title":"Eur. J. Pediatr."},{"key":"86663_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/brain\/119.2.523","volume":"119","author":"A Diamond","year":"1996","unstructured":"Diamond, A. & Herzberg, C. Impaired sensitivity to visual contrast in children treated early and continuously for phenylketonuria. Brain 119, 523\u2013538 (1996).","journal-title":"Brain"},{"key":"86663_CR25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41390-018-0202-x","volume":"85","author":"D Rausell","year":"2018","unstructured":"Rausell, D. et al. Newly validated biomarkers of brain damage may shed light into the role of oxidative stress in the pathophysiology of neurocognitive impairment in dietary restricted phenylketonuria patients. Pediatr. Res. 85, 242\u2013250 (2018).","journal-title":"Pediatr. Res."},{"key":"86663_CR26","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1007\/s10571-017-0573-2","volume":"38","author":"B Kumru","year":"2018","unstructured":"Kumru, B. et al. Effect of blood phenylalanine levels on oxidative stress in classical phenylketonuric patients. Cell Mol. Neurobiol. 38, 1033\u20131038 (2018).","journal-title":"Cell Mol. Neurobiol."},{"key":"86663_CR27","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/bpa.12645","volume":"28","author":"C Laule","year":"2018","unstructured":"Laule, C. & Moore, G. R. W. Myelin water imaging to detect demyelination and remyelination and its validation in pathology. Brain Pathol. 28, 750\u2013764 (2018).","journal-title":"Brain Pathol."},{"key":"86663_CR28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/PAT.0000000000000210","volume":"47","author":"RA Williams","year":"2015","unstructured":"Williams, R. A., Hooper, A. J., Bell, D. A., Mamotte, C. D. S. & Burnett, J. R. Plasma cholesterol in adults with phenylketonuria. Pathology 47, 134\u2013137 (2015).","journal-title":"Pathology"},{"key":"86663_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13023-016-0508-x","volume":"11","author":"ML Couce","year":"2016","unstructured":"Couce, M. L. et al. Lipid profile status and other related factors in patients with Hyperphenylalaninaemia. Orphanet. J. Rare Dis. 11, 123 (2016).","journal-title":"Orphanet. J. Rare Dis."},{"key":"86663_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4172\/2471-2663.1000130","volume":"3","author":"KM Stepien","year":"2017","unstructured":"Stepien, K. M. & Hendriksz, C. J. Low serum cholesterol concentration in adult patients with phenylketonuria-one centre experience. Clin. Med. Biochem. 3, 2 (2017).","journal-title":"Clin. Med. Biochem."},{"key":"86663_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13023-018-0839-x","volume":"13","author":"GAM Parra","year":"2018","unstructured":"Parra, G. A. M., Singh, R. H., Cetinyurek-Yavuz, A., Kuhn, M. & MacDonald, A. Status of nutrients important in brain function in phenylketonuria: A systematic review and meta-analysis. Orphanet. J. Rare Dis. 13, 101\u2013117 (2018).","journal-title":"Orphanet. J. Rare Dis."},{"key":"86663_CR32","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/BF00973296","volume":"13","author":"M Castillo","year":"1988","unstructured":"Castillo, M., Zafra, M. F. & Garcia-Peregrin, E. Inhibition of brain and liver 3-hydroxy-3-methylglutaryl-CoA reductase and mevalonate-5-pyrophosphate decarboxylase in experimental hyperphenylalaninemia. Neurochem. Res. 13, 551\u2013555 (1988).","journal-title":"Neurochem. Res."},{"key":"86663_CR33","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/1097-4547(20000901)61:5<549::AID-JNR10>3.0.CO;2-0","volume":"61","author":"S Shefer","year":"2000","unstructured":"Shefer, S. Is there a relationship between 3-hydroxy-3-methylglutaryl coenzyme a reductase activity and forebrain pathology in the PKU mouse?. J. Neurosci. Res. 61, 549\u2013563 (2000).","journal-title":"J. Neurosci. Res."},{"key":"86663_CR34","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/nn1426","volume":"8","author":"Saher","year":"2005","unstructured":"Saher, et al. High cholesterol level is essential for myelin membrane growth. Nat. Neurosci. 8, 468\u2013475 (2005).","journal-title":"Nat. Neurosci."},{"key":"86663_CR35","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1055\/s-2008-1071394","volume":"11","author":"HK Blomquist","year":"1980","unstructured":"Blomquist, H. K., Gustavson, K. H. & Holmgren, G. Severe mental retardation in five siblings due to maternal phenyketonuria. Neuropediatrics 11, 256\u2013261 (1980).","journal-title":"Neuropediatrics"},{"key":"86663_CR36","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1001\/archopht.1983.01040020238016","volume":"101","author":"J Zwaan","year":"1983","unstructured":"Zwaan, J. Eye findings in patients with phenylketonuria. Arch. Ophthalmol. 101, 1236\u20131237 (1983).","journal-title":"Arch. Ophthalmol."},{"key":"86663_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3928\/0191-3913-19850301-12","volume":"22","author":"L Cotticelli","year":"1985","unstructured":"Cotticelli, L. et al. Ophthalmological findings of phenylketonuria: A survey of 14 cases. J. Pediatr. Ophthalmol. Strabismus. 22, 78\u201379 (1985).","journal-title":"J. Pediatr. Ophthalmol. Strabismus."},{"key":"86663_CR38","first-page":"36","volume":"7","author":"ME Mohallal","year":"2016","unstructured":"Mohallal, M. E., Hefty, H. A., Elsayyad, H. I. & Ebied, H. M. Histopathological effects on the eye development during perinatal growth of albino rats maternally treated with experimental PKU during pregnancy. J. Ad. Lab. Res. Biol. 7, 36\u201342 (2016).","journal-title":"J. Ad. Lab. Res. Biol."},{"key":"86663_CR39","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1006\/exer.1993.1003","volume":"56","author":"ML Robinson","year":"1993","unstructured":"Robinson, M. L., Holmgren, A. & Dewey, M. J. Genetic control of ocular morphogenesis: Defective lens development associated with ocular anomalies in C57BL\/6 mice. Exp. Eye Res. 56, 7\u201316 (1993).","journal-title":"Exp. Eye Res."},{"key":"86663_CR40","first-page":"551","volume":"44","author":"RS Smith","year":"1994","unstructured":"Smith, R. S., Roderick, T. H. & Sundberg, J. P. Microphthalmia and associated abnormalities in inbred black mice. Lab. Anim. Sci. 44, 551\u2013560 (1994).","journal-title":"Lab. Anim. Sci."},{"key":"86663_CR41","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/jmg.10.2.101","volume":"10","author":"PCH Newbold","year":"1973","unstructured":"Newbold, P. C. H. The skin in genetically-controlled metabolic disorders. J. Med. Genet. 10, 101\u2013111 (1973).","journal-title":"J. Med. Genet."},{"key":"86663_CR42","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/179199b0","volume":"179","author":"M Miyamoto","year":"1957","unstructured":"Miyamoto, M. & Fitzpatrick, T. B. Competitive inhibition of mammalian tyrosinase by phenylalanine and its relationship to hair pigmentation in phenylketonuria. Nature 179, 199\u2013200 (1957).","journal-title":"Nature"},{"key":"86663_CR43","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0166-4328(01)00401-6","volume":"132","author":"RMJ Deacon","year":"2002","unstructured":"Deacon, R. M. J., Croucher, A. & Rawlins, J. N. P. Hippocampal cytotoxic lesion effects on species-typical behaviors in mice. Behav. Brain Res. 132, 203\u2013213 (2002).","journal-title":"Behav. Brain Res."},{"key":"86663_CR44","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ymgme.2017.10.009","volume":"123","author":"SR Winn","year":"2018","unstructured":"Winn, S. R., Scherer, T. & Harding, C. O. Blood phenylalanine reduction corrects CNS dopamine and serotonin deficiencies and partially improves behavioral performance in adult phenyketonuric mice. Mol. Genet. Metab. 123, 6\u201320 (2018).","journal-title":"Mol. Genet. Metab."},{"key":"86663_CR45","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1073\/pnas.1620506114","volume":"114","author":"HA Ferris","year":"2017","unstructured":"Ferris, H. A. et al. Loss of astrocyte cholesterol synthesis disrupts neuronal function and alters whole-body metabolism. Proc. Natl. Acad. Sci. 114, 1189\u20131194 (2017).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"86663_CR46","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34, 184\u2013191 (2016).","journal-title":"Nat. Biotechnol."},{"key":"86663_CR47","doi-asserted-by":"publisher","first-page":"16006","DOI":"10.1038\/mtm.2016.6","volume":"3","author":"S Kyostio-Moore","year":"2016","unstructured":"Kyostio-Moore, S. et al. The impact of minimally oversized adeno-associated viral vectors encoding human Factor VIII on vector potency in vivo. Mol. Ther. Methods Clin. Dev. 3, 16006 (2016).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"86663_CR48","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ymgme.2013.05.011","volume":"109","author":"N Yew","year":"2013","unstructured":"Yew, N. et al. Erythrocytes encapsulated with phenylalanine hydroxylase exhibit improved pharmacokinetics and lowered plasma phenylalanine levels in normal mice. Mol. Gen. Metab. 109, 339\u2013344 (2013).","journal-title":"Mol. Gen. Metab."},{"key":"86663_CR49","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0378-4347(00)00553-3","volume":"753","author":"A Kankaanp\u00e4\u00e4","year":"2001","unstructured":"Kankaanp\u00e4\u00e4, A., Meririnne, E., Ariniemi, K. & Sepp\u00e4l\u00e4, T. Oxalic acid stabilizes dopamine, serotonin, and their metabolites in automated liquid chromatography with electrochemical detection. J. Chromatogr. B. Biomed. Sci. Appl. 753, 413\u2013419 (2001).","journal-title":"J. Chromatogr. B. Biomed. Sci. Appl."},{"key":"86663_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1759091418777329","volume":"10","author":"J Cao","year":"2018","unstructured":"Cao, J. et al. In vivo optical imaging of myelination events in a myelin basic protein promoter-driven luciferase transgenic mouse model. ASN Neuro 10, 1\u201314 (2018).","journal-title":"ASN Neuro"},{"key":"86663_CR51","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/0361-9230(92)90141-J","volume":"29","author":"KW Kaatz","year":"1992","unstructured":"Kaatz, K. W., Bazzett, T. J. & Albin, R. L. A new, simple myelin stain. Brain Res. Bull. 29, 697\u2013698 (1992).","journal-title":"Brain Res. Bull."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86663-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86663-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86663-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T04:11:24Z","timestamp":1675051884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-86663-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,31]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["86663"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-86663-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,31]]},"assertion":[{"value":"25 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors were employees of Sanofi at the time of manuscript work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7254"}}